Migraine, Headache News & Research | Migraine & Headache Treatment

Migraine and Headache


Feature Article


brain cells neurons

CGRP-Binding Monoclonal Antibodies Safe for Prevention of Episodic Migraine

Short-term use of calcitonin-gene-related peptide (CGRP) binding monoclonal antibodies was well-tolerated and safe when used to prevent episodic migraine, according to a study published in Cephalalgia. The investigators of this study sought to evaluate and compare the safety and tolerability of CGRP binding monoclonal antibodies for the preventative treatment of episodic migraine. The investigators systematically…
Next post in Migraine & Headache